Genetic basis for tailored drug therapy for ventricular arrhythmias

Back

EHRA Premium Access

Genetic basis for tailored drug therapy for ventricular arrhythmias

Session: Critical appraisal of antiarrhythmic drug therapy - The science behind trial-and-error

Topic: Arrhythmias

Speaker: Associate Professor C. Remme (Amsterdam, NL)

Event: EHRA 2019

Congress Presentation

About the speaker

Associate Professor Carol Ann Remme

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

12 presentations

3 followers

4 more presentations in this session

The trials-and-errors of antiarrhythmic drug therapy

Speaker: Professor J. Camm (London, GB)

Access

Slides

Video

Rationale behind development of novel drugs for atrial arrhythmias

Speaker: Professor J. Heijman (Graz, AT)

Access

Slides

Video

Antiarrhythmic drugs - What, why, when to whom

Speaker: Professor G. Dan (Bucharest, RO)

Access

Panel discussion

Access

Video

Access the full session

Critical appraisal of antiarrhythmic drug therapy - The science behind trial-and-error

Speakers: Associate Professor C. Remme, Professor J. Camm, Professor J. Heijman, Professor G. Dan

Access

About the event

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress

Genetic basis for tailored drug therapy for ventricular arrhythmias

About the speaker

Associate Professor Carol Ann Remme

4 more presentations in this session

The trials-and-errors of antiarrhythmic drug therapy

Rationale behind development of novel drugs for atrial arrhythmias

Antiarrhythmic drugs - What, why, when to whom

Panel discussion

Access the full session

Critical appraisal of antiarrhythmic drug therapy - The science behind trial-and-error

About the event

EHRA 2019

ESC 365 is supported by